AccScience Publishing

Cancer Plus is a new research journal that aims to provide a peer-reviewed, open-access platform for researchers and practitioners to present novel and high-impact articles in the field of cancer research and clinical trials. This is a joint collaboration journal between Shan'xi Academy of Medical Sciences (China), Shan'xi Bethune Hospital (China), and the Chinese Academy of Sciences. Areas of interest for this journal include, but are not limited to, the following topics:

Mechanisms of tumorigenesis
Genetic alterations of cancer
Epigenetics of cancer
Cell signalling
Cancer stem cells
Cancer prevention
Diagnosis
Cancer drugs/chemotherapy/therapeutic methods
Clinical trials

2. Ownership

The journal is owned by Accscience Publishing and co-organized with Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences (China).

3. Publishing Model

Gold open access. All articles published by CP are made freely and permanently accessible online immediately from the date of publication. For further information, please refer to Open Access Policy.

4. Copyright and License to Publish

License
Articles in Cancer Plus are published under a Creative Commons Attribution 4.0 International (CC BY 4.0). The CC BY 4.0 allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license, users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.

5. Editorial Board

For more information about the editorial team, please refer to Editorial Board.

6. Editorial Policies

All manuscripts submitted to CP should adhere to AccScience Publishing's Editorial Policies.

7. Manuscript Processing System

ASP serves a diverse global community of scholars, committed to freely sharing cutting-edge research under the Creative Commons Attribution (CC BY) license. To enhance the precision, academic rigor, and timeliness of our publications, we have developed the proprietary, cutting-edge manuscript processing system known as the OSS (Online Submission System).

Queries regarding Special Issues, manuscript submissions, editorial policies and other related matters may be directed to the Journal Editorial Office.

8. Peer Review

The journal adheres to rigorous peer review and undergoes double-blind peer review. For more details, please refer to Editorial Process.

9. Publication Ethics Statement

CP fully adheres to the the Committee on Publication Ethics (COPE).

The Editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to guarantee to add high-quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The Editors of CP take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero-tolerance policy. To verify the originality of content submitted to our journals, we use CrossCheck (powered by iThenticate) to check submissions against previous publications.

10. Journal Information and Statistics

ISSN 2661-3840 (Online)
Digital archive: Portico
Frequency: Quarterly published
DOI: 10.36922/cp

11. Indexing & Archiving

All articles published in CP are included in Google Scholar and ASCI (Asian Science Citation Index).

12. Contact

Please visit the page of Editorial Office for details about different queries.

Cancer Plus, Electronic ISSN: 2661-3840 Print ISSN: 2661-3832, Published by AccScience Publishing